Lantern Pharma Inc (NAS:LTRN)
$ 3.81 0.05 (1.33%) Market Cap: 41.01 Mil Enterprise Value: 7.43 Mil PE Ratio: 0 PB Ratio: 1.32 GF Score: 39/100

Q1 2022 Lantern Pharma Inc. Earnings Call Transcript

May 03, 2022 / 08:30PM GMT
Release Date Price: $6.06 (+5.03%)
Nicole Leber
Lantern Pharma Inc. - IR Associate, Finance & Administrative Coordinator

Good afternoon, everybody. I'm Nicole Leber with Investor Relations here at Lantern Pharma, and welcome to our First Quarter 2022 Earnings Call. I will be your host for today's call. As a reminder, this call is being recorded. (Operator Instructions) We will open up the call for questions and answers after management's presentation. Webcast replay of today's conference call will be available on our website at lanternpharma.com after the call.

We issued a press release after the market closed today, summarizing our financial results and progress across the company for the first quarter of 2022. A copy of this release is available through our website where you can also find a link to the slides that management will be referencing on today's call.

I would like to remind everybody about that remarks about future expectations, claims and prospectus constitute forward-looking statements for purposes of safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Lantern Pharma

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot